rs142008398

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1

The NM_032444.4(SLX4):​c.3676C>T​(p.Arg1226Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000213 in 1,613,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

SLX4
NM_032444.4 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:3

Conservation

PhyloP100: 1.14
Variant links:
Genes affected
SLX4 (HGNC:23845): (SLX4 structure-specific endonuclease subunit) This gene encodes a protein that functions as an assembly component of multiple structure-specific endonucleases. These endonuclease complexes are required for repair of specific types of DNA lesions and critical for cellular responses to replication fork failure. Mutations in this gene were found in patients with Fanconi anemia. [provided by RefSeq, Sep 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0048915446).
BP6
Variant 16-3589962-G-A is Benign according to our data. Variant chr16-3589962-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 456313.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=3, Benign=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00103 (157/152064) while in subpopulation AFR AF= 0.00364 (151/41482). AF 95% confidence interval is 0.00317. There are 0 homozygotes in gnomad4. There are 68 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLX4NM_032444.4 linkuse as main transcriptc.3676C>T p.Arg1226Trp missense_variant 12/15 ENST00000294008.4 NP_115820.2 Q8IY92-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLX4ENST00000294008.4 linkuse as main transcriptc.3676C>T p.Arg1226Trp missense_variant 12/155 NM_032444.4 ENSP00000294008.3 Q8IY92-1

Frequencies

GnomAD3 genomes
AF:
0.00103
AC:
157
AN:
151946
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00365
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000959
GnomAD3 exomes
AF:
0.000327
AC:
82
AN:
250660
Hom.:
0
AF XY:
0.000214
AC XY:
29
AN XY:
135700
show subpopulations
Gnomad AFR exome
AF:
0.00442
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000128
AC:
187
AN:
1461804
Hom.:
0
Cov.:
37
AF XY:
0.000109
AC XY:
79
AN XY:
727206
show subpopulations
Gnomad4 AFR exome
AF:
0.00418
Gnomad4 AMR exome
AF:
0.000246
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000144
Gnomad4 OTH exome
AF:
0.000331
GnomAD4 genome
AF:
0.00103
AC:
157
AN:
152064
Hom.:
0
Cov.:
32
AF XY:
0.000915
AC XY:
68
AN XY:
74320
show subpopulations
Gnomad4 AFR
AF:
0.00364
Gnomad4 AMR
AF:
0.000262
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000949
Alfa
AF:
0.000175
Hom.:
0
Bravo
AF:
0.00109
ESP6500AA
AF:
0.00432
AC:
19
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000379
AC:
46
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Fanconi anemia Uncertain:1Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 11, 2023- -
Uncertain significance, criteria provided, single submittercurationSema4, Sema4Oct 18, 2021- -
Fanconi anemia complementation group P Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsNov 13, 2019This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
not specified Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingGenetic Services Laboratory, University of ChicagoSep 08, 2022DNA sequence analysis of the SLX4 gene demonstrated a sequence change, c.3676C>T, in exon 12 that results in an amino acid change, p.Arg1226Trp. This sequence change has been previously described in familial breast cancer cases (PMID: 23840564). This sequence change has been described in the gnomAD database with a frequency of 0.4% in the African/African American subpopulation (dbSNP rs142008398). The p.Arg1226Trp change affects a poorly conserved amino acid residue located in a domain of the SLX4 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Arg1226Trp substitution. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Arg1226Trp change remains unknown at this time. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxMay 25, 2021Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function -
SLX4-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 18, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.72
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.55
T
M_CAP
Benign
0.038
D
MetaRNN
Benign
0.0049
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.4
L
PrimateAI
Benign
0.19
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.055
Sift
Uncertain
0.0070
D
Sift4G
Uncertain
0.012
D
Polyphen
0.99
D
Vest4
0.20
MVP
0.24
MPC
0.21
ClinPred
0.023
T
GERP RS
0.24
Varity_R
0.065
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142008398; hg19: chr16-3639963; COSMIC: COSV53561119; API